Company: AX
Filing Date: 2025-09-16
Form Type: 424B5
Source: 0001299709-25-000147
Chunk: 23

Company: Axos Financial, Inc.
Filing Date: 2025-09-16
Form: 424B5
Chunk 23
---
 determinations, decisions or elections could have a material adverse effect on the yield on, value of and market for the Notes. Any determination by us, as the calculation agent, will be final and binding absent manifest error.

The use of the net proceeds from the sale of the Notes will be at the discretion of our management and could change depending on unforeseen events or changes in current business conditions or our circumstances.

While, our current intention is to use the net proceeds from this offering to repay existing indebtedness, including the redemption in full of the 2030 Notes, of which $160.5 million in principal amount is currently outstanding, to support growth initiatives at the Company ’ s subsidiaries and for general corporate purposes, as discussed further under “ Use of Proceeds ” below (and this prospectus supplement generally assumes that the 2030 Notes will be redeemed with those proceeds), our management will have broad discretion in the use of the net proceeds from the sale of the Notes. The descriptions in this prospectus supplement of our use of the proceeds from the sale of the Notes represent our current intentions based upon our present plans and business conditions. The occurrence of any unforeseen events or change in business conditions, however, could result in the application of the net proceeds of the offering in a manner other than as described in this prospectus supplement.

Federal tax legislative proposals could impact your investment.

New tax legislation is from time to time introduced in the U.S. Congress and current law may change. We cannot be certain if, when or in what form any such new tax law may be enacted and whether any such law will apply to instruments issued earlier than the effective date of such law or to entities in existence earlier than the effective date of such law. It is possible that additional legislation could be introduced and enacted by the current U.S. Congress or future Congresses that could have an adverse impact on investors in the Notes. We suggest prospective investors consult with their tax advisors as to the potential impact of legislative proposals.

<div align='center'>S-14</div>

### USE OF PROCEEDS
Our estimated net proceeds from this offering are approximately $ assuming an aggregate offering price of $ and after deducting commissions and estimated expenses of the offering.

We intend to use the net proceeds from this offering to repay existing indebtedness, including the redemption in full of the 2030 Notes, of which $160.5 million in principal amount is currently outstanding, to support growth initiatives at the Company ’ s subsidiaries and for general corporate purposes. While it is our current intention